Methadone Dose and Timing of Administration as Predictors of Sleep Apnea Syndrome During Methadone Maintenance Treatment: A Retrospective Cross-sectional Study
- PMID: 38322484
- PMCID: PMC10843352
- DOI: 10.34172/ahj.2023.1455
Methadone Dose and Timing of Administration as Predictors of Sleep Apnea Syndrome During Methadone Maintenance Treatment: A Retrospective Cross-sectional Study
Abstract
Background: This study aimed to assess the association of sleep apnea syndrome (SAS) with methadone dose and timing of administration in patients receiving methadone maintenance treatment (MMT) for opioid use disorder (OUD).
Methods: This retrospective cross-sectional study was conducted on adult patients receiving MMT who had a nocturnal respiratory polygraphy between November 2015 and December 2021. Data on methadone treatment and polygraph recording, including the apnea-hypopnea index (AHI) were collected.
Findings: A total of 40 patients, mostly male (72.5%), with a mean age of 35±6.7 years and a mean body mass index (BMI) of 25.1±4.5 kg/m2 were included. The daily dose of methadone was significantly associated with an AHI≥15 events/h as well as an AHI≥30 events/h, even after adjustment for age, gender, BMI, and benzodiazepine use. However, these associations were not preserved when the time of administration (day vs evening) was considered, while the evening administration was significantly associated with an AHI≥15 events/h. The best sensitivity and specificity for the prediction of AHI≥15 events/h and AHI≥30 events/h were obtained with daily methadone doses of≥72.5 mg and 77.5 mg, respectively.
Conclusion: In this sample of MMT patients, methadone doses of 72.5 mg and 77.5 mg were the best cut-off values for predicting AHI≥15 and≥30 events/h, respectively, especially when taken in the evening. These results should draw clinicians' attention to the importance of SAS screening, and further studies are needed, notably comparisons with buprenorphine.
Keywords: Methadone; Opioid-related disorders; Sleep apnea syndrome.
© 2023 Kerman University of Medical Sciences.
Conflict of interest statement
Competing Interests The authors declare no competing interest.
Similar articles
-
Respiratory Variability during Sleep in Methadone Maintenance Treatment Patients.J Clin Sleep Med. 2016 Apr 15;12(4):607-16. doi: 10.5664/jcsm.5702. J Clin Sleep Med. 2016. PMID: 26943710 Free PMC article.
-
The No-apnea score vs. the other five questionnaires in screening for obstructive sleep apnea-hypopnea syndrome in patients with cerebral infarction.J Thorac Dis. 2019 Oct;11(10):4179-4187. doi: 10.21037/jtd.2019.09.75. J Thorac Dis. 2019. PMID: 31737301 Free PMC article.
-
Utility of the STOP-BANG components to identify sleep apnea using home respiratory polygraphy.Sleep Breath. 2015 Dec;19(4):1327-33. doi: 10.1007/s11325-015-1174-2. Epub 2015 Apr 24. Sleep Breath. 2015. PMID: 25903074
-
A narrative review: The effects of opioids on sleep disordered breathing in chronic pain patients and methadone maintained patients.Am J Addict. 2016 Sep;25(6):452-65. doi: 10.1111/ajad.12424. Am J Addict. 2016. PMID: 27554389 Review.
-
Maxillomandibular Advancement for Treatment of Obstructive Sleep Apnea: A Meta-analysis.JAMA Otolaryngol Head Neck Surg. 2016 Jan;142(1):58-66. doi: 10.1001/jamaoto.2015.2678. JAMA Otolaryngol Head Neck Surg. 2016. PMID: 26606321 Review.
References
LinkOut - more resources
Full Text Sources